1177 related articles for article (PubMed ID: 16890276)
1. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
2. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
3. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
4. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
6. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
7. Primary pelvic exenteration in cervical cancer patients.
Ungar L; Palfalvi L; Novak Z
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
9. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
10. [Pelvic exenteration, morbidity and survival].
Méndez L; Bernal A; Escudero P; González G; Fajardo A
Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration for recurrent endometrial cancer.
Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma.
Houvenaeghel G; Lelievre L; Gonzague-Casabianca L; Buttarelli M; Moutardier V; Goncalves A; Resbeut M
Gynecol Oncol; 2006 Feb; 100(2):338-43. PubMed ID: 16213008
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
14. [Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases].
Janser JC; Rodier JF; Rodier D; Vergnes Y
Chirurgie; 1994-1995; 120(8):409-14; 414-5. PubMed ID: 7648894
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
17. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
[TBL] [Abstract][Full Text] [Related]
18. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
19. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.
Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC
Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Morris M; Alvarez RD; Kinney WK; Wilson TO
Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]